FOI 5229 – Australian Teletrial Program Quarterly Reports, March 2022 To March 2024

Written by Claude Haiku 4.5 from the extracted text on 27 Feb 2026. It can miss or misread redacted and scanned pages. Check the source before relying on it.

This FOI release contains quarterly progress reports from the Australian Teletrial Program, a Medical Research Future Fund initiative led by Queensland Health spanning October 2021 to October 2026. The program aims to establish national infrastructure enabling remote clinical trials across Australian jurisdictions. Early reports (March 2022 reporting period) show the program executed subcontracts with jurisdictional partners and convened steering committees. Key harmonisation activities included developing a Teletrials Toolkit implemented across Queensland sites and standardised nationally, and drafting a national Patient Information Consent Form for teletrials endorsed through the National Mutual Acceptance group. The program engaged broadly with Human Research Ethics Committees, research governance officers, and clinical coordinators across Queensland Health. The documents track milestone completion percentages and timelines, showing initial progress on contract execution and governance structures needed to support remote clinical trial delivery across multiple Australian health jurisdictions.